, Tracking Stock Market Picks
Enter Symbol:
China Biologic Products Inc (CBPO) [hlAlert]

up 101.37 %

China Biologic Products Inc (CBPO) upgraded to Buy with price target $55 by Aegis Capital

Posted on: Tuesday,  Jul 8, 2014  12:00 AM ET by Aegis Capital

Aegis Capital rated Buy China Biologic Products Inc (NASDAQ: CBPO) on 07/08/2014, when the stock price was $49.58.
Since then, China Biologic Products Inc has gained 101.37% as of 10/08/2015's recent price of $99.84.
If you would have followed this Aegis Capital's recommendation on CBPO, you would have gained 101.37% of your investment in 457 days.

China Biologic Products, Inc. is a biopharmaceutical company and through its Chinese subsidiaries, Shandong Taibang and Qianfeng, and Huitian, the Company is engaged in the research, development and manufacturing of plasma-based pharmaceutical products in China. It sells human albumin, which represented approximately 49.7% during the year ended December 31, 2009. Human albumin is principally used to increase blood volume while immunoglobulin is used for certain disease preventions and cures. The Company sells human albumin 20%/10ml, 20%/25ml, 20%/50ml, 10%/10ml, 10%/25ml, 10%/50ml and 25%/50ml. It sells the products to customers in the People Republic of China (PRC), mainly hospitals and inoculation centers. In June 2009, it purchased 35% interest in Xi'an Huitian Blood Products Co., Ltd. On December 21, 2009, the Company established Logic Management and Consulting (China) Co., Ltd.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/8/2014 12:00 AM Buy
49.58 55.00
as of 10/17/2014
1 Week down  -0.09 %
1 Month down  -4.13 %
3 Months up  15.48 %
1 YTD up  4.82 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/6/2013 3:25 PM Hold
3/14/2013 10:25 AM Buy
25.11 28.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy